XML 12 R6.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash flows from operating activities    
Net Income (Loss) $ 5,070 $ 3,991
Adjustments to reconcile net income to net cash provided by operating activities    
Amortization of net loan fees and discount/premiums on loans receivable (675) (936)
Income from equity method investments 681 (609)
Distributions of earnings from equity method investments 489 1,120
Amortization of deferred financing costs 425 241
Provision for credit loss 15 3,164
Increase or decrease in operating assets and liabilities    
Decrease in accrued interest receivable 1,380 70
Decrease in other assets (17) (21)
Decrease in reimbursement receivable 0 147
(Decrease) in related party payables and accrued expenses (1,079) (65)
Increase in reimbursement payable 307 0
(Decrease) increase in incentive fee payable (477) 749
(Decrease) increase in management fee payable (15) 1,032
Increase in accounts payable and accrued expenses 789 217
(Decrease) increase in other liabilities (185) 410
Net cash provided by operating activities 6,708 9,510
Cash flows from investing activities    
Origination and purchase of mortgage loan receivables (202,072) (2,953)
Subsequent draws on mortgage loan receivables (3,907) 0
Repayment of mortgage loan receivables 126,156 12,000
Distributions from equity method investments in excess of earnings 1,747 0
Net cash (used for) provided by investing activities (78,076) 9,047
Cash flows from financing activities    
Issuance of common units 3,078 2,987
Distributions paid (8,269) (8,233)
Decrease in redemption payable (4,094) 0
Credit facility borrowings 203,700 0
Credit facility paydowns (108,700) 0
Repurchase agreement borrowings 41,300 0
Repurchase agreement paydowns (447) (9,600)
Note payable borrowings 0 0
Note payable paydowns (55,250) 0
Deferred financing costs paid (63) (36)
Net cash provided by (used for) financing activities 71,255 (14,882)
Net (decrease) increase in cash and cash equivalents (113) 3,675
Cash and cash equivalents, beginning of period 10,913 26,622
Cash and cash equivalents, end of period 10,800 30,297
Supplemental financing activities    
Cash paid during the period for interest 9,128 8,357
Redemptions payable $ 2,917 $ 0